EGF and breast carcinoma: For example, altering actin nucleation rates can modulate the stress fluctuation magnitudes in the cytoskeleton, a phenotype observed in intracellular microrheology experiments that modulate epidermal growth factor (EGF) signaling (known to influence actin nucleation) in breast cancer cells [33].